Oncotarget: Breast Cancer Cells To Onc201 From Anti-Proliferative To Apoptotic

Oncotarget: Breast cancer cells to ONC201 from anti-proliferative to apoptotic

Oncotarget: ONC201, TRAIL, and Breast Cancer

Oncotarget: ONC201 kills breast cancer cells in vitro by targeting mitochondria

Oncotarget: Combination Therapeutics Inhibit Breast Cancer Resistance

Inhibition of Resistant Triple-negative Breast Cancer Cells | Oncotarget

Oncotarget: Akt Antagonist Drug and Th1 Cytokines Combat Breast Cancer

Oncotarget: Phenotypic Changes in HER2+ Breast Cancer

Oncotarget: Researchers identify potential therapeutic target in aggressive breast cancer cells

Oncotarget: Osteoprotegerin rich tumor microenvironment: implications in breast cancer

Secretomes from Metastatic Breast Cancer Cells and MSC Actions | Oncotarget

GPR141 Mediates Breast Cancer Proliferation and Metastasis | Oncotarget

MTAP Loss in Metastatic Breast Cancer Patients: Genomic Landscape | Oncotarget

Continuous Abemaciclib Treatment Leads to Breast Cancer Inhibition | Oncotarget

Oncotarget: Anti-psychotic drug could treat aggressive breast cancer

Oncotarget | NOTCH1 Variants in Triple-Negative Breast Cancer

Oncotarget: CRISPR Used in Triple Negative Breast Cancer Research

Breast Cancer Cell Subpopulations Fueling Invasion and Metastasis | Oncotarget

Crosstalk Between Triple Negative Breast Cancer and Microenvironment | Oncotarget

Breast Cancer Survivors and Weight Loss | Oncotarget

Oncotarget | Neutrophil Density Associated With Breast Cancer Prognosis